GC
MJN

Globeflex Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Globeflex Capital’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-57,693
Closed -$5.38M – 716
2014
Q2 		$5.38M Sell
57,693
-283
-0.5% -$24.7K 0.58% 61
2014
Q1 		$4.82M Sell
57,976
-264
-0.5% -$21.4K 0.55% 71
2013
Q4 		$4.88M Buy
+58,240
New +$4.74M 0.59% 65

Other funds holding MJN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Globeflex Capital's MJN Position: Q3 2014 in Review

Globeflex Capital sold out of Mead Johnson Nutrition Company (MJN) in Q3 2014, closing a stake of 57,693 shares — an estimated $5.38M sold.

Globeflex Capital first reported a position in MJN in Q4 2013 and held it in 3 quarters. The position peaked at $5.38M in Q2 2014. 524 funds tracked by Wall St. Rank hold MJN as of Q3 2014.

  • Globeflex Capital reported no remaining Mead Johnson Nutrition Company position as of Q3 2014 after selling out during the quarter.
  • Globeflex Capital sold 57,693 Mead Johnson Nutrition Company shares in Q3 2014, an estimated $5.38M.
  • Globeflex Capital first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 3 quarters.
  • Globeflex Capital's Mead Johnson Nutrition Company position peaked at $5.38M in Q2 2014.
  • 524 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2014.

Based on Globeflex Capital's 13F filing for Q3 2014, filed 15 Oct 2014.